|Location:||Kingston upon Hull|
|Funding for:||UK Students, EU Students, International Students|
|Funding amount:||£17,668 per annum|
|Hours:||Full Time, Part Time|
|Placed On:||16th January 2023|
|Closes:||10th February 2023|
About this project
Applications are invited for an exciting 3-year fully funded PhD studentship to commence in September 2023.
The studentship is part of an interdisciplinary programme of work supervised by Dr Holly Wilkinson, Prof Mat Hardman and Prof Steve Archibald at the Hull York Medical School. The project provides a unique opportunity to use molecular imaging to determine the factors that cause poor wound healing, alongside developing new theragnostic strategies to treat chronic wounds.
The project will provide an unprecedented opportunity to identify and target senescent cells in wounds using molecular imaging and novel theragnostic agents. The student will perform detailed mechanistic studies as well as testing the potential to re-purpose existing theragnostic drugs for the treatment of chronic wounds.
For informal inquiries, please contact Dr Holly Wilkinson (firstname.lastname@example.org).
About the research cluster / about the research environment
Theragnostics is a rapidly developing area of nuclear medicine which combines diagnosis and therapy into a single unified strategy for the treatment of disease. We are already implementing approved theragnostics into the clinic at Castle Hill Hospital, for the benefit of cancer patients in the surrounding area. Complementary to this is our ambition to expand our own research capacity around novel theragnostic radiopharmaceuticals and their application to disease. In 2022, we established the Hull University Theragnostics (HUT) PhD cluster. The cluster unites two successful research groups in molecular imaging and wound research, to collaborate and explore new ground in theragnostic radiopharmaceutical development with applications in cancer and wounds.
Main supervisor: Dr Holly Wilkinson
Co-supervisors: Prof Mat Hardman, Prof Steve Archibald
Submission of thesis
Submission of your final thesis is expected within three years and three months from the start of your PhD scholarship for full-time and within five years and six months if studying part-time.
Eligibility and entry requirements
This studentship will appeal to a candidate with a strong interest in the Biomedical area. You will require an undergraduate degree with at least a 2.1, or MSc/MRes, in a relevant subject (Biomedical Science, Biochemistry or related discipline). If English is not your first language you will require a valid English certificate equivalent to IELTS 6.5+ with a minimum of 6.0 in all components.
This opportunity comes with a Home fee waiver only, which will not cover the full International fee. You will therefore need to pay the difference between the Home fee and the International fee and will need to provide evidence that you have sufficient funds to cover this.
How to apply Applications are via the University of Hull webpage
Closing date for applications
10 February 2022
Type / Role: